Glasgow Coma Scales and General Anesthesia

NCT ID: NCT03521414

Last Updated: 2018-05-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-03

Study Completion Date

2015-11-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study evaluates the general anesthesia management with BIS monitorization in terms of hemodynamic stability, drug concentrations and drug consumption in patients who underwent surgery due to intracranial pathology and who were divided in three different GCS groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

BIS monitoring is mostly used for anesthesia depth and sedation level follow-up, however it can also be used for monitoring consciousness after resuscitation of cases with acute brain injury and cardiac arrest. It is not always possible to monitor and objectively measure the changes in the level of consciousness in clinical practice. Therefore, device-based methods have been introduced in monitoring the state of consciousness. Bispectral index (BIS) monitoring may be preferred in follow up of the state of consciousness in critical patients such as those with acute brain injury, in terms of ease of use, ability to obtain numerical results and continuous monitoring. BIS monitoring is mostly used for follow up of anesthesia depth and sedation level, while it can also be applied for monitoring state of consciousness following resuscitation in cases with acute brain injury and cardiac arrest.In this study, we aimed to investigate general anesthesia management performed by bispectral index monitoring in patients who underwent surgery due to intracranial pathology and with different Glasgow Coma Scales.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia Awareness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I=13-15 mildly injured

Patients were divided into 3 groups according to the Glasgow Coma Scores calculated before surgery. use of anesthetic agent were recorded during bispectral index (BIS) monitoring and anesthesia application. we used sevoflurane drug intraoperative.

Group I (n=15)=13-15 mildly injured

Group Type ACTIVE_COMPARATOR

Bispectral index (BIS) monitoring

Intervention Type DEVICE

When the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug

Sevoflurane

Intervention Type DRUG

we used sevoflurane drug at inoperative

Group 2 =9-12 moderately damaged

Patients were divided into 3 groups according to the Glasgow Coma Scores calculated before surgery.use of anesthetic agent were recorded during bispectral index (BIS) monitoring and anesthesia application. we used sevoflurane drug intraoperative.

Group 2 (n=15)=9-12 moderately damaged

Group Type ACTIVE_COMPARATOR

Bispectral index (BIS) monitoring

Intervention Type DEVICE

When the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug

Sevoflurane

Intervention Type DRUG

we used sevoflurane drug at inoperative

Group 3=3-8 severely damaged.

Patients were divided into 3 groups according to the Glasgow Coma Scores calculated before surgery. use of anesthetic agent were recorded during bispectral index (BIS) monitoring and anesthesia application. we used sevoflurane drug intraoperative.

Group 3 (n=15)=3-8 severely damaged.

Group Type ACTIVE_COMPARATOR

Bispectral index (BIS) monitoring

Intervention Type DEVICE

When the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug

Sevoflurane

Intervention Type DRUG

we used sevoflurane drug at inoperative

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bispectral index (BIS) monitoring

When the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug

Intervention Type DEVICE

Sevoflurane

we used sevoflurane drug at inoperative

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 and 65 years
* ASA II-III
* intracranial surgery

Exclusion Criteria

* Patients with additional disease (electrolyte impairment, uremia, etc.),
* liver and renal failure affecting consciousness level other than intracranial pathology
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Trakya University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sevtap Hekimoglu Sahin

Director, clinical research

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TÜTF-GOKAEK 2013/127

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.